A Phase III Trial to Evaluate the Immunogenicity and Safety of HPV Vaccine

Conditions: Human Papillomavirus Infection Interventions: Biological: nonavalent HPV study vaccine; Biological: GARDASIL ® 9 Sponsors: Beijing Health Guard Biotechnology, Inc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials